CLIN. BREAST CANCER: AI-Driven Accuracy and Efficiency in Breast Cancer Diagnosis

A study conducted at The Ohio State University Wexner Medical Center confirms that Ibex Breast significantly improves accuracy and efficiency in evaluating breast pathology cases. The findings, published in Clinical Breast Cancer, demonstrate how AI technology can assist pathologists in providing patients with quicker and more trusted diagnostic results.

The study analyzed 104 real-world breast biopsies; three expert breast pathologists independently reviewed each case digitally, both with and without the support of Ibex Breast.  Pathologists using Ibex Breast saw clear benefits:

  • Diagnostic accuracy improved to 100%
  • Up to 23% reduction in case review time
  • An average 33% decrease in diagnostic IHC orders.

Click the image below to read the peer-reviewed publication.

Abstract of breast cancer research

Share this article:

Subscribe to our newsletter:

By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.

How is artificial intelligence rising to the challenge in breast cancer diagnosis?
How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News
The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics
Scroll to Top
IBEX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.